 | 5'-N-Ethylcarboxamidoadenosine | IC50 | 16.0 [1], 23.0 [2], 67.0 [3] |
| 5'-N-Ethylcarboxamidoadenosine | Ki | 1.0 [1], 16.0 [2], 130.0 [3], 680.0 [4] |
 | 8-Cyclopentyl-1,3-dipropylxanthine | IC50 | 217.0 [1], 261.0 [2] |
 | 4-{2-[(7-Amino-2-Furan-2-Yl[1,2,4]triazolo[1,5-A][1,3,5]triazin-5-Yl)amino]ethyl}phenol | IC50 | 0.68 [1], 1.45 [2], 33.11 [3], 41.69 [4], 80.8 [5] |
| 4-{2-[(7-Amino-2-Furan-2-Yl[1,2,4]triazolo[1,5-A][1,3,5]triazin-5-Yl)amino]ethyl}phenol | Ki | 0.8 [1] |
 | 2-Cl-IB-Meca | Ki | 5400.0 [1] |
 | IB-Meca | Ki | 116.0 [1], 2900.0 [2] |
 | 2-(Furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine | IC50 | 12.0 [1] |
| 2-(Furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine | Ki | 1.1 [1], 4.3 [2] |
 | Istradefylline | IC50 | 5248.07 [1] |
| Istradefylline | Ki | 12.0 [1] |
 | 2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | IC50 | 19.0 [1] |
| 2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | Ki | 50.0 [1] |
 | 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine | IC50 | 12.0 [1] |
 | Caffeine | Ki | 23400.0 [1] |
 | N6-Cyclopentyladenosine | Ki | 385.0 [1] |
 | Mcp-neca | Ki | 140.0 [1] |
 | 2-Chloro-N6-cyclopentyladenosine | Ki | 17.0 [1], 580.0 [2] |
 | Preladenant | Ki | 1.1 [1] |
 | 4-(Furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine | Ki | 0.05 [1] |
 | 2-Butyl-9-methyl-8-(triazol-2-yl)purin-6-amine | IC50 | 430.0 [1] |
| 2-Butyl-9-methyl-8-(triazol-2-yl)purin-6-amine | Ki | 6.6 [1], 10.7 [2] |
 | 5'-Amino-5'-deoxyadenosine | Ki | 52.0 [1], 407.0 [2], 492.0 [3], 534.0 [4], 604.0 [5] |
 | Binodenoson | Ki | 81.0 [1], 270.0 [2] |
 | 1-[11-Ethyl-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-3-(4-methoxyphenyl)urea | Ki | 1040.0 [1], 1045.0 [2] |
 | CID 11248240 | Ki | 2300.0 [1] |
 | Unii-djf621DE4F | IC50 | 0.4 [1] |
| Unii-djf621DE4F | Ki | 2.3 [1], 6.0 [2], 46.0 [3] |
 | 4-(3-(5-Amino-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)propyl)phenol | IC50 | 10.0 [1] |
| 4-(3-(5-Amino-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)propyl)phenol | Ki | 1.5 [1], 48.0 [2], 48.3 [3] |
 | Apadenoson | Ki | 0.5 [1] |
 | (2R,3R,4S,5R)-2-(6-Amino-2-(phenylethynyl)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol | Ki | 363.0 [1] |
 | CID 10046145 | Ki | 5.0 [1], 5.38 [2], 15.0 [3] |
 | 4-(Furan-2-yl)-11-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-amine | Ki | 0.31 [1], 0.34 [2] |
 | 2'Methyl-2-chloro-N6-cyclopentyladenosine | Ki | 3.9 [1], 4560.0 [2], 9580.0 [3] |
 | 5-Butyl-8-[4-(trifluoromethyl)phenyl]-1H-[1,2,4]triazolo[5,1-f]purine | IC50 | 10000.0 [1] |
| 5-Butyl-8-[4-(trifluoromethyl)phenyl]-1H-[1,2,4]triazolo[5,1-f]purine | Ki | 31.0 [1], 10000.0 [2] |
 | (2R,3R,4S)-2-(6-(3-Iodobenzylamino)-2-chloro-9H-purin-9-yl)-tetrahydrothiophene-3,4-diol | Ki | 341.0 [1] |
 | N-(2-Furan-2-yl-6-pyrazol-1-yl-pyrimidin-4-yl)-acetamide | Ki | 0.6 [1] |
 | 4-(Furan-2-yl)-10-(3-phenylpropyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine | IC50 | 18.0 [1] |
| 4-(Furan-2-yl)-10-(3-phenylpropyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine | Ki | 1.2 [1] |
 | 8-(4-(4-Benzylpiperazin-1-ylsulfonyl)phenyl)-1-propyl-1H-purine-2,6(3H,7H)-dione | Ki | 484.0 [1] |
 | (2S,3S,4R,5R)-5-[2-Chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N,N-dimethyloxolane-2-carboxamide | Ki | 10000.0 [1] |
 | (2S,3S,4R,5R)-5-[2-Chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N,N-dimethylthiolane-2-carboxamide | Ki | 10000.0 [1] |
 | 5-Methyl-2-phenylpyrazolo[4,3-d]pyrimidin-7-amine | Ki | 246.0 [1] |
 | 2,5-Diphenylpyrazolo[4,3-d]pyrimidin-7-amine | Ki | 325.0 [1] |
 | 5-Benzyl-2-phenylpyrazolo[4,3-d]pyrimidin-7-amine | Ki | 110.0 [1] |
 | 4-[6-Amino-9-methyl-8-(triazol-2-yl)purin-2-yl]butan-2-one | IC50 | 990.0 [1] |
| 4-[6-Amino-9-methyl-8-(triazol-2-yl)purin-2-yl]butan-2-one | Ki | 12.0 [1] |
 | 4-[6-Amino-9-methyl-8-(triazol-2-yl)purin-2-yl]butan-2-ol | IC50 | 450.0 [1] |
| 4-[6-Amino-9-methyl-8-(triazol-2-yl)purin-2-yl]butan-2-ol | Ki | 8.0 [1], 8.4 [2] |
 | N-[2-(3,5-Dimethylpyrazol-1-yl)-6-(5-methoxypyridin-3-yl)pyrimidin-4-yl]acetamide | IC50 | 57.0 [1], 85.0 [2] |
| N-[2-(3,5-Dimethylpyrazol-1-yl)-6-(5-methoxypyridin-3-yl)pyrimidin-4-yl]acetamide | Ki | 2.3 [1] |
 | Nifedipine | Ki | 22200.0 [1], 244000.0 [2] |
 | Amiloride | Ki | 3280.0 [1], 11600.0 [2], 12000.0 [3] |
 | Galangin | Ki | 16700.0 [1], 18100.0 [2], 33000.0 [3] |
 | (R)-N-(1-Methyl-2-phenylethyl)adenosine | Ki | 750.0 [1], 884.0 [2] |
 | 8-(3-Chlorostyryl)caffeine | Ki | 36.0 [1], 38.1 [2], 204.2 [3] |
 | Dpma | Ki | 18.9 [1], 35.9 [2], 38.1 [3] |
 | Cvt-6883 | Ki | 3280.0 [1], 10000.0 [2] |
 | Tonapofylline | Ki | 6400.0 [1], 6410.0 [2] |
 | Tozadenant | Ki | 0.3 [1], 5.0 [2], 11.0 [3] |
 | 7-Chloro-4-hydroxy-2-phenyl-1,8-naphthyridine | Ki | 100.0 [1], 450.0 [2] |
 | N(6)-(2,2-Diphenylethyl)adenosine | Ki | 49.9 [1], 510.0 [2] |
 | 2-Hydroxymethyl-5-[6-(3-iodo-benzylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol | Ki | 20.4 [1], 121.0 [2], 140.0 [3] |
 | Unii-8L3oaj1R5A | IC50 | 4.0 [1] |
| Unii-8L3oaj1R5A | Ki | 4.0 [1] |
 | Tert-butyl 1-[(2R,3S)-3-[[(2S)-4-amino-4-oxo-2-(phenylmethoxycarbonylamino)butanoyl]amino]-2-hydroxy-4-phenylbutyl]pyrrolidine-2-carboxylate | Ki | 6.4 [1] |
 | 1-[4-(Furan-2-yl)-11-methyl-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-3-(4-methoxyphenyl)urea | Ki | 1390.0 [1] |
 | Sonedenoson | Ki | 58.5 [1], 490.0 [2] |
 | 1-(3-Chlorophenyl)-3-[11-ethyl-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]urea | Ki | 180.0 [1], 185.0 [2] |
 | 1-[11-Butyl-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-3-(4-methoxyphenyl)urea | Ki | 80.0 [1] |
 | 1-(3-Chlorophenyl)-3-[4-(furan-2-yl)-11-propyl-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]urea | Ki | 1220.0 [1], 1221.0 [2] |
 | 4-(Furan-2-yl)-11-(3-phenylpropyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-amine | Ki | 0.16 [1], 0.18 [2] |
 | N-[2-[[2-Phenyl-6-[4-(3-phenylpropyl)piperazine-1-carbonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethyl]acetamide | Ki | 328.0 [1] |
 | (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-[6-(methylamino)-2-(2-phenylethynyl)purin-9-yl]oxolane-3,4-diol | Ki | 8530.0 [1] |
 | 4-Benzyl-7-methyl-2-propyl-6H-purino[7,8-a]imidazole-1,3-dione | Ki | 1000.0 [1] |
 | N-Cyclopentyl-2'-C-methyl-adenosine | Ki | 7220.0 [1], 7560.0 [2], 10400.0 [3] |
 | 2-(4-Methyl-1H-1,3-benzodiazol-2-yl)quinoxaline | Ki | 833.0 [1] |
 | 5-Butyl-8-phenyl-1H-[1,2,4]triazolo[5,1-f]purine | IC50 | 71.0 [1] |
 | 2-Amino-8-(2-morpholinoethoxy)-4-phenyl-5H-indeno[1,2-d]pyrimidin-5-one | Ki | 6.5 [1] |
 | 2-Phenyl-1,8-naphthyridin-4-ol | Ki | 2000.0 [1], 10000.0 [2] |
 | (2S,3S,4R,5R)-3,4-Dihydroxy-5-[6-[(3-iodophenyl)methylamino]purin-9-yl]-N-methylthiolane-2-carboxamide | Ki | 475.0 [1] |
 | 2-(4-Fluorophenyl)-7-methyl-1,8-naphthyridin-4-ol | Ki | 440.0 [1], 630.0 [2] |
 | (1S,2R,3S,4R,5S)-4-[2-Chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-2,3-dihydroxy-N-methylbicyclo[3.1.0]hexane-1-carboxamide | Ki | 784.0 [1] |
 | 2-Phenyl-7-methoxy-1,8-naphthyridine-4-ol | Ki | 490.0 [1], 1400.0 [2] |
 | 7-Bromo-2-phenyl-[1,8]naphthyridin-4-ol | Ki | 66.0 [1], 100.0 [2] |
Calculator
